Literature DB >> 19885588

Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice.

Ying Xie1, Zheng-Bo Wei, Zhe Zhang, Wensheng Wen, Guang-Wu Huang.   

Abstract

Photodynamic therapy (PDT) is a promising treatment for nasopharyngeal carcinoma. However, recurrence and metastasis of the tumor after PDT remains problematic. In this study we investigated VEGF and PCNA expression in tumor tissues after 5-ALA-PDT. BALB/c nude mice with NPC tumors of similar size were randomly assigned to three groups (n=10 each). In the two treatment groups, mice were administrated 5-ALA intratumorally at a dose of 100 mg/kg and 3-3.5 h prior to laser irradiation (630 nm, 100 J/cm(2), 100 mW/cm(2)). The mice in one of the treatment groups were sacrificed at 24 h after PDT. The other treatment group and control group mice were sacrificed 14 days after PDT, and the tumor weights were determined for all three groups. Mean tumor weights at 14 days after PDT were 1.353+/-0.204 g in the treatment group and 3.124+/-0.380 g in the control group (p<0.001). Results showed the VEGF level in tumor tissues at 24 h after PDT was slightly higher than that in the control group, while it was down-regulated at 14 days after PDT. The PCNA level was not significantly different in tumor tissues among the three groups, but it was lower in degenerated tumor cells 24 h after PDT. Our results suggest that VEGF may play a role in tumor recurrence and metastasis following PDT. Residual tumor cells escaped from PDT is the main reason for tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885588     DOI: 10.3892/or_00000576

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.

Authors:  Allison Marrero; Theresa Becker; Ulas Sunar; Janet Morgan; David Bellnier
Journal:  Photochem Photobiol       Date:  2011-06-13       Impact factor: 3.421

2.  Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results.

Authors:  G Fabbrocini; M C Annunziata; M Donnarumma; S Cacciapuoti; C Marasca; A Tosti
Journal:  Support Care Cancer       Date:  2018-02-10       Impact factor: 3.603

3.  Nanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment.

Authors:  Rumwald Leo G Lecaros; Leaf Huang; Tsai-Chia Lee; Yih-Chih Hsu
Journal:  Mol Ther       Date:  2015-09-16       Impact factor: 11.454

4.  Pyogenic granuloma in a patient with psoriasis successfully treated by 5-aminolevulinic acid photodynamic therapy: A case report.

Authors:  Juan Liu; Bing-Rong Zhou; Fei Yi; Hong-Jin Wu; Jia-An Zhang; Dan Luo
Journal:  Exp Ther Med       Date:  2015-11-27       Impact factor: 2.447

5.  Reactive oxygen species involved cancer cellular specific 5-aminolevulinic acid uptake in gastric epithelial cells.

Authors:  Hiromu Ito; Masato Tamura; Hirofumi Matsui; Hideyuki J Majima; Hiroko P Indo; Ichinosuke Hyodo
Journal:  J Clin Biochem Nutr       Date:  2014-03-01       Impact factor: 3.114

6.  Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species.

Authors:  Zhe-Yu Hu; Jing Wang; Gang Cheng; Xiao-Feng Zhu; Peng Huang; Dajun Yang; Yi-Xin Zeng
Journal:  Chin J Cancer       Date:  2011-01

Review 7.  Animal models for photodynamic therapy (PDT).

Authors:  Zenildo Santos Silva; Sandra Kalil Bussadori; Kristianne Porta Santos Fernandes; Ying-Ying Huang; Michael R Hamblin
Journal:  Biosci Rep       Date:  2015-09-28       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.